|
HS Code |
728392 |
| Name | Ginkgolic Acid |
| Chemical Formula | C17H27O3 |
| Molecular Weight | 279.39 g/mol |
| Cas Number | 15291-77-7 |
| Appearance | White to off-white powder |
| Melting Point | 67-69°C |
| Solubility | Insoluble in water, soluble in organic solvents |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Synonyms | 6-Alkylsalicylic acid |
| Source | Ginkgo biloba leaves |
| Hazard Statements | May cause skin and eye irritation |
As an accredited Ginkgolic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ginkgolic Acid is packaged in a 1g amber glass vial with a secure screw cap, labeled for laboratory use only. |
| Shipping | Ginkgolic Acid is shipped in tightly sealed containers, protected from light and moisture, at cool temperatures. It is classified as a hazardous chemical and must comply with all relevant transport regulations. Proper labeling, documentation, and handling precautions are enforced to ensure safety during transit and delivery. |
| Storage | Ginkgolic Acid should be stored in a tightly sealed container, protected from light and moisture. It should be kept in a cool, dry place, ideally in a refrigerator at 2-8°C. Avoid exposure to heat, direct sunlight, and incompatible substances. Proper labeling and secure storage away from food and incompatible chemicals are essential for safety and stability. |
|
Purity 98%: Ginkgolic Acid with purity 98% is used in neuropharmacological studies, where it enhances the accuracy of neuroprotective activity assessments. Molecular Weight 316.43 g/mol: Ginkgolic Acid with molecular weight 316.43 g/mol is used in bioactive compound screening, where it ensures consistent reproducibility in experimental protocols. Melting Point 145°C: Ginkgolic Acid with a melting point of 145°C is used in pharmaceutical synthesis, where it provides thermal stability during compound formulation. Particle Size <10 µm: Ginkgolic Acid with particle size less than 10 µm is used in in vitro cell culture assays, where it promotes uniform cellular uptake and reliable cytotoxicity measurements. Stability Temperature up to 40°C: Ginkgolic Acid with stability temperature up to 40°C is used in biochemical reagent kits, where it maintains bioactivity under standard laboratory storage conditions. Solubility in DMSO 20 mg/mL: Ginkgolic Acid with solubility in DMSO at 20 mg/mL is used in enzyme inhibition assays, where it allows for high-concentration dose testing with minimal precipitation. HPLC Assay ≥99%: Ginkgolic Acid with HPLC assay purity of at least 99% is used in analytical reference standards, where it ensures high accuracy in quantification and detection limits. Residual Solvent <0.5%: Ginkgolic Acid with residual solvent content less than 0.5% is used in bioassay development, where it reduces interference in biological activity measurements. |
Competitive Ginkgolic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ginkgolic Acid, a natural compound found in Ginkgo biloba, has raised both curiosity and concern in research labs, wellness circles, and pharmaceutical discussions. The journey of this molecule isn’t typical; tucked within the seeds and leaves of the Ginkgo tree, it mirrors the plant’s ancient reputation for resilience while also hinting at nature’s complexities that require respect. In recent years, scientists and health professionals have turned their attention to ginkgolic acid’s specific structure, pharmacological promise, and challenges, seeking to untangle myth from evidence and value from risk.
The Ginkgo biloba tree bridges ancient medicine and modern science. Its leaves have long symbolized clarity and memory, and its extracts surround conversations about cognitive support. What stands out, though, is ginkgolic acid’s dual role as both a point of therapeutic interest and a red flag for safety. Unlike the much-touted flavonoids and terpenoids in Ginkgo supplements, ginkgolic acid attracts attention for its cytotoxicity at higher concentrations. Anyone looking for plant-based solutions should know the nuanced difference: where ginkgolides might promote circulatory health, ginkgolic acid serves as a cautionary tale on plant toxicity.
The structure of ginkgolic acid sharply distinguishes it from the more benign constituents in Ginkgo extracts. Chemically, ginkgolic acid refers to a group of alkylphenols, typically comprised of a 6-alkylsalicylic acid backbone. The main variants—C13:0, C15:1, and C17:1—differ by the length and saturation of their alkyl side chain. This specificity matters not only for identification but also for possible biological effects. Researchers routinely use high-performance liquid chromatography (HPLC) and mass spectrometry to pinpoint which analog is present, as even minute differences influence both safety and pharmacology.
Commercially available ginkgolic acid often appears as a yellowish powder, and purity can range from crude isolates found in plant extracts to nearly pure, analytically calibrated standards required for laboratory research. Commonly, purity levels above 95% are preferred for in-depth pharmacological testing, minimizing interference from related compounds. Laboratory bottles might list each variant’s concentration, affirming quality for experimental reproducibility. In my lab days, we checked every new batch for specificity, because so much of our downstream data—whether cell proliferation, enzyme inhibition, or toxicity—dependent on that fine chemical consistency.
Researchers first noticed ginkgolic acid’s potential through its inhibitory effect on various enzymes and signaling pathways. It drew early interest for antibacterial and antifungal properties, long before its association with Ginkgo supplements reached the wider public. In pharmacology circles, attention soon shifted to more ambitious targets: tumor cell lines, metabolic disorders, inflammatory pathways, and as an adjunct to experimental cancer therapies.
Reports document selective apoptosis in certain cancer cell types exposed to purified ginkgolic acid, though at concentrations that far exceed what dietary exposure from Ginkgo supplements could provide. Enzymatic studies highlight its capacity for SIRT inhibition, disrupting protein deacetylation and impacting cellular stress responses. Neuropharmacology experiments probe whether the molecule affects neural pathways linked to memory retention or neuroprotection, but so far, its potential toxicity looms larger than any therapeutic benefits for the brain.
Many conversations about Ginkgo-based products fixate on cognitive claims or blood flow. Ginkgolic acid sits in a different bracket altogether—more relevant to experimental biochemistry than off-the-shelf supplementation. Regulatory agencies trace the presence of ginkgolic acid closely: concentrations in commercial Ginkgo leaf extracts must remain below strict thresholds, typically under 5 ppm, due to toxicity risk. Cases of allergic reactions, gastrointestinal upset, and even severe dermatitis in sensitive individuals have all been traced to higher exposures, not to mention genotoxic and cytotoxic effects seen in lab settings.
Ginkgo supplements flood store shelves, promising a panacea for aging minds and tired bodies. They often trumpet standardized levels of flavonol glycosides and terpene lactones, which have shown some benefit in vascular health and antioxidant capacity. Ginkgolic acid occupies a different space—one less about enhancement and more about vigilance. Its mechanism, rooted in cell signaling disruption and lipid interaction, stands out in the Ginkgo profile.
In the context of extraction and preparation, standardized Ginkgo products focus on maximizing potentially beneficial components while minimizing toxic ones like ginkgolic acid. Producers employ solvent extraction, filtration, and purification steps, aiming for ginkgolic acid levels below the regulatory ceiling. If these controls falter, supplements could easily breach safety margins. This risk feels personal; I recall colleagues needing several rounds of purification to bring ginkgolic content into compliance, sometimes failing entire production batches when testing revealed levels above guidelines.
By contrast, laboratory use flips the script: high-purity ginkgolic acid enables researchers to isolate specific biological effects. We see the distinction most clearly in side-by-side cell line experiments. Where ginkgo flavonoids might limit oxidative damage without apparent toxicity, ginkgolic acid’s cytotoxicity reveals itself through cell death markers and pro-inflammatory signaling.
Comparing ginkgolic acid to other plant-derived compounds reminds us that “natural” doesn’t always mean “safe.” Take salicylic acid from willow bark—a close structural relative but worlds apart in effect and safety. Salicylic acid supports pain relief and anti-inflammatory uses, while ginkgolic acid remains a research candidate hemmed in by stringent dose limitations.
The problem with many herbal extracts comes down to standardization and unpredictable chemistry. Ginkgolic acid’s effects shift not only with dose, but also between batches, preparations, and even geographic sources of Ginkgo. Unlike the relatively static makeup of vitamin C in ascorbic supplements, or the known structure of ibuprofen, ginkgolic acid’s presence fluctuates wildly, which is a big reason government agencies remain strict about testing and labeling.
Ginkgo’s wider medicinal profile also features compounds like bilobalide and ginkgolides, known for platelet-activating factor antagonism and potential neuroprotective effects. No credible evidence exists to suggest ginkgolic acid offers neuroprotection; instead, the focus always returns to risk management and the crucial task of minimizing accidental exposure.
Safety stands as the cornerstone of all ginkgolic acid discussions. Reports document allergic responses in people exposed to ginkgo seed shells and extracts containing elevated ginkgolic acid. The related poison ivy family shares structural motifs, which helps explain these hypersensitivity reactions. Toxicology research from the last decade links ginkgolic acid to mitochondrial dysfunction, reactive oxygen species production, and impaired cellular energy production at even modest exposure. In one widely cited study, rats exposed to small quantities over time developed signs of kidney and liver stress. This matters for everything from supplement quality to occupational safety in extraction plants.
International regulatory agencies established a maximum allowable content in commercial Ginkgo extracts, highlighting the widespread recognition of potential toxicity. The World Health Organization, along with regulatory regimes in North America, Europe, and parts of Asia, maintain similar caps on ginkgolic acid in finished products. These regulatory moves reflect broad scientific consensus based on decades of toxicological work.
In clinical settings, physicians worry most about Ginkgo users with allergies, sensitivities, or those already at risk of bleeding disorders and medication interactions. Cases of contact dermatitis linked to Ginkgo seeds almost always track back to unrefined preparations with elevated ginkgolic acid.
The responsibility for safe ginkgolic acid levels doesn’t rest solely with producers; robust supply chain transparency and third-party analysis make the crucial difference. Reliable suppliers publish public-facing certificates of analysis showing not just active ingredient strength, but contaminant levels, including ginkgolic acid. In my career, the labs that adopted frequent, third-party batch testing caught problems early. The ones that skipped this usually paid the price in recall costs and reputational damage.
End users—pharmacists, clinicians, and consumers—benefit directly from this vigilance. Pharmaceutical-grade Ginkgo extracts, for example, undergo multiple rounds of purification, and their certificates confirm compliance with international quality standards. Some supplement brands distinguish themselves by not just saying “ginkgolic acid-free,” but by publishing analytic test results. As a scientist and regular consumer, I always look for this transparency: it builds trust and offers proof, not just marketing claims.
Ginkgolic acid’s complexity offers room for discovery, though any practical therapeutic use must squarely address toxicity. Ongoing research explores structural modification, searching for analogs with retained enzyme inhibition but minimized cell toxicity. Other teams design delivery systems limiting ginkgolic acid’s systemic exposure, hoping to harness its bioactivity at lower, safer doses. Early results are promising in the petri dish, but translating these gains to animal or human studies remains a huge challenge.
Environmental research tracks the ways ginkgolic acid cycles in soil and water near Ginkgo plantations. These efforts matter, especially in regions with high extract production; the leaching of alkylphenols into soil or water threatens non-target plant and microbial communities. Research into waste remediation, filtration advances, and green chemistry processes encourages responsible stewardship without compromising production efficiency.
For those considering Ginkgo supplements or research products, trusting the source is the first line of defense. Reputable brands share third-party test results and show a consistent record of regulatory compliance. Health professionals help by guiding patients toward products with documented testing and by reviewing any supplement use in medication histories—especially before surgery or when managing chronic conditions.
In research, clear documentation, safe handling, and waste protocols for ginkgolic acid help shield staff from accidental exposure. Labs tracking cell culture responses must link every dataset to specific batch records, so that unanticipated outcomes can be traced to a source. My own mistakes usually came from skipping that extra documentation step, which only became obvious once confusion arose about variable toxicity outcomes.
The history of ginkgolic acid mirrors the wider journey of botanical medicine—promising, complicated, sometimes treacherous. Plant extracts promise natural solutions, but nature rarely operates by human safety standards. Ginkgolic acid reminds us how precision matters in extraction, testing, and the honest representation of product contents. Trust emerges less from claims and more from consistent, transparent practice.
Ginkgo continues to offer new surprises and fresh research questions. For its part, ginkgolic acid carves out a unique place: a molecular challenge demanding respect, vigilance, and careful application. As research pushes boundaries on enzyme inhibition, cancer therapy adjuncts, and the fine tuning of plant-based compounds, the lasting lessons of ginkgolic acid remain: never overlook possible risks in the search for reward, and always make science the bedrock of health decisions.
For readers looking to dive deeper, major pharmacognosy journals, toxicology reports, and Ginkgo biloba monographs offer reliable overviews, as do public health advisories published by the World Health Organization and national regulatory agencies. Investigating these primary sources builds a strong foundation for understanding both the science and the responsible use of Ginkgo extracts and their potent molecular passengers, including ginkgolic acid.